Cargando…

Acceptable risks of treatments to prevent rheumatoid arthritis among first-degree relatives: demographic and psychological predictors of risk tolerance

OBJECTIVES: To quantify tolerance to risks of preventive treatments among first-degree relatives (FDRs) of patients with rheumatoid arthritis (RA). METHODS: Preventive treatments for RA are under investigation. In a preference survey, adult FDRs assumed a 60% chance of developing RA within 2 years a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Simons, Gwenda, Janssen, Ellen M, Veldwijk, Jorien, DiSantostefano, Rachael L, Englbrecht, Matthias, Radawski, Christine, Valor-Méndez, Larissa, Humphreys, Jennifer H, Bruce, Ian N, Hauber, Brett, Raza, Karim, Falahee, Marie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2022
Materias:	Rheumatoid Arthritis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9748990/ https://www.ncbi.nlm.nih.gov/pubmed/36598004 http://dx.doi.org/10.1136/rmdopen-2022-002593

Ejemplares similares

Preferences for preventive treatments for rheumatoid arthritis: discrete choice survey in the UK, Germany and Romania
por: Simons, Gwenda, et al.
Publicado: (2022)

Maximum Acceptable Risk Estimation Based on a Discrete Choice Experiment and a Probabilistic Threshold Technique
por: Veldwijk, Jorien, et al.
Publicado: (2023)

Predictors of perceived risk in first-degree relatives of patients with rheumatoid arthritis
por: Bunnewell, Sarah, et al.
Publicado: (2022)

Treatment preferences for preventive interventions for rheumatoid arthritis: protocol of a mixed methods case study for the Innovative Medicines Initiative PREFER project
por: Falahee, Marie, et al.
Publicado: (2021)

Systematic review of quantitative preference studies of treatments for rheumatoid arthritis among patients and at-risk populations
por: Simons, Gwenda, et al.
Publicado: (2022)

I Would Never Take Preventive Medication! Perspectives and Information Needs of People Who Underwent Predictive Tests for Rheumatoid Arthritis
por: Mosor, Erika, et al.
Publicado: (2020)

Rheumatoid arthritis prevention: any takers?
por: Falahee, Marie, et al.
Publicado: (2021)

Depression and anxiety in an early rheumatoid arthritis inception cohort. associations with demographic, socioeconomic and disease features
por: Fragoulis, George E, et al.
Publicado: (2020)

Initial validation and results of the Symptoms in Persons At Risk of Rheumatoid Arthritis (SPARRA) questionnaire: a EULAR project
por: van Beers-Tas, Marian H, et al.
Publicado: (2018)

Metabolomic profiles, polygenic risk scores and risk of rheumatoid arthritis: a population-based cohort study in the UK Biobank
por: Fang, Xin-Yu, et al.
Publicado: (2023)

Role of Anti–Carbamylated Protein Antibodies Compared to Anti–Citrullinated Protein Antibodies in Indigenous North Americans With Rheumatoid Arthritis, Their First‐Degree Relatives, and Healthy Controls
por: Koppejan, H., et al.
Publicado: (2016)

Enhancing Patient Understanding of Medication Risks and Benefits
por: Blalock, Susan J., et al.
Publicado: (2021)

A core set of risk factors in individuals at risk of rheumatoid arthritis: a systematic literature review informing the EULAR points to consider for conducting clinical trials and observational studies in individuals at risk of rheumatoid arthritis
por: Mankia, Kulveer, et al.
Publicado: (2021)

Interplay between obesity and smoking with regard to RA risk
por: Hedström, Anna Karin, et al.
Publicado: (2019)

Risk for infections with glucocorticoids and DMARDs in patients with rheumatoid arthritis
por: Riley, Thomas R, et al.
Publicado: (2021)

Hydroxychloroquine and the risk of respiratory infections among RA patients
por: Kremer, Joel M, et al.
Publicado: (2020)

Is rheumatoid arthritis a risk factor for acute coronary syndrome also among individuals at elevated risk, such as individuals presenting with acute chest pain?
por: Svensson, Per, et al.
Publicado: (2020)

Association of Sputum Neutrophil Extracellular Trap Subsets With IgA Anti–Citrullinated Protein Antibodies in Subjects at Risk for Rheumatoid Arthritis
por: Okamoto, Yuko, et al.
Publicado: (2021)

Herpes Zoster and Tofacitinib: Clinical Outcomes and the Risk of Concomitant Therapy
por: Winthrop, Kevin L., et al.
Publicado: (2017)

Complex role of oestrogens in the risk and severity of rheumatoid arthritis in menopause
por: Cutolo, Maurizio, et al.
Publicado: (2023)

Risk Factors for Falls in Adults With Rheumatoid Arthritis: A Prospective Study
por: Stanmore, Emma K, et al.
Publicado: (2013)

Impact of Sustained Remission on the Risk of Serious Infection in Patients With Rheumatoid Arthritis
por: Accortt, Neil A., et al.
Publicado: (2018)

Risk of lung cancer in rheumatoid arthritis and in relation to autoantibody positivity and smoking
por: Chatzidionysiou, Katerina, et al.
Publicado: (2022)

Risk of breast cancer before and after rheumatoid arthritis, and the impact of hormonal factors
por: Wadström, Hjalmar, et al.
Publicado: (2020)

Diurnal patterns of sedentary time in rheumatoid arthritis: associations with cardiovascular disease risk
por: Fenton, Sally A M, et al.
Publicado: (2020)

Diabetes mellitus and cardiovascular risk management in patients with rheumatoid arthritis: an international audit
por: Semb, Anne Grete, et al.
Publicado: (2021)

Genetic Liability to Rheumatoid Arthritis in Relation to Coronary Artery Disease and Stroke Risk
por: Yuan, Shuai, et al.
Publicado: (2022)

Cardiovascular disease risk in patients with inflammatory arthritis nowadays still substantially elevated
por: Raadsen, Reinder, et al.
Publicado: (2023)

A Risk Score to Detect Subclinical Rheumatoid Arthritis–Associated Interstitial Lung Disease
por: Juge, Pierre‐Antoine, et al.
Publicado: (2022)

Added value of multiple autoantibody testing for predicting progression to inflammatory arthritis in at-risk individuals
por: Ponchel, Frederique, et al.
Publicado: (2022)

Mortality Trends in Patients With Early Rheumatoid Arthritis Over 20 Years: Results From the Norfolk Arthritis Register
por: Humphreys, J H, et al.
Publicado: (2014)

Features of the Synovium of Individuals at Risk of Developing Rheumatoid Arthritis: Implications for Understanding Preclinical Rheumatoid Arthritis
por: de Hair, MJH, et al.
Publicado: (2014)

Depression as a risk factor for the development of rheumatoid arthritis: a population-based cohort study
por: Vallerand, Isabelle A, et al.
Publicado: (2018)

Risk factors for venous thromboembolism and atherosclerotic cardiovascular disease: do they differ in patients with rheumatoid arthritis?
por: Ozen, Gulsen, et al.
Publicado: (2021)

Disease-modifying anti-rheumatic drugs associated with different diabetes risks in patients with rheumatoid arthritis
por: Su, Yu-Jih, et al.
Publicado: (2023)

Risk of Incident Diabetes Mellitus Associated With the Dosage and Duration of Oral Glucocorticoid Therapy in Patients With Rheumatoid Arthritis
por: Movahedi, Mohammad, et al.
Publicado: (2016)

Effects of alcohol consumption and smoking on risk for RA: results from a Swedish prospective cohort study
por: Hedenstierna, Louise, et al.
Publicado: (2021)

How to enhance recruitment of individuals at risk of rheumatoid arthritis into trials aimed at prevention: understanding the barriers and facilitators
por: van Boheemen, Laurette, et al.
Publicado: (2021)

Lifetime risk of rheumatoid arthritis-associated interstitial lung disease in MUC5B mutation carriers
por: Palomäki, Antti, et al.
Publicado: (2021)

Multiomics analysis of rheumatoid arthritis yields sequence variants that have large effects on risk of the seropositive subset
por: Saevarsdottir, Saedis, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mtfcgf3k2t51cgntqfp7bhl9fv